Literature DB >> 22134538

MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.

Alfa H C Bai1, Till Milde, Marc Remke, Claudio G Rolli, Thomas Hielscher, Yoon-Jae Cho, Marcel Kool, Paul A Northcott, Manfred Jugold, Alexandr V Bazhin, Stefan B Eichmüller, Andreas E Kulozik, Armin Pscherer, Axel Benner, Michael D Taylor, Scott L Pomeroy, Ralf Kemkemer, Olaf Witt, Andrey Korshunov, Peter Lichter, Stefan M Pfister.   

Abstract

The contribution of microRNAs to the initiation, progression, and metastasis of medulloblastoma (MB) remains poorly understood. Metastatic dissemination at diagnosis is present in about 30% of MB patients, and is associated with a dismal prognosis. Using microRNA expression profiling, we demonstrate that the retinal miR-183-96-182 cluster on chromosome 7q32 is highly overexpressed in non-sonic hedgehog MBs (non-SHH-MBs). Expression of miR-182 and miR-183 is associated with cerebellar midline localization, and miR-182 is significantly overexpressed in metastatic MB as compared to non-metastatic tumors. Overexpression of miR-182 in non-SHH-MB increases and knockdown of miR-182 decreases cell migration in vitro. Xenografts overexpressing miR-182 invaded adjacent normal tissue and spread to the leptomeninges, phenotypically reminiscent of clinically highly aggressive large cell anaplastic MB. Hence, our study provides strong in vitro and in vivo evidence that miR-182 contributes to leptomeningeal metastatic dissemination in non-SHH-MB. We therefore reason that targeted inhibition of miR-182 may prevent leptomeningeal spread in patients with non-SHH-MB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134538     DOI: 10.1007/s00401-011-0924-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Can miRNA-based real-time PCR be used to classify medulloblastomas?

Authors:  Vijay Ramaswamy; Nardin Samuel; Marc Remke
Journal:  CNS Oncol       Date:  2014-05

2.  BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.

Authors:  Martje Tönjes; Sebastian Barbus; Yoon Jung Park; Wei Wang; Magdalena Schlotter; Anders M Lindroth; Sabrina V Pleier; Alfa H C Bai; Daniela Karra; Rosario M Piro; Jörg Felsberg; Adele Addington; Dieter Lemke; Irene Weibrecht; Volker Hovestadt; Claudio G Rolli; Benito Campos; Sevin Turcan; Dominik Sturm; Hendrik Witt; Timothy A Chan; Christel Herold-Mende; Ralf Kemkemer; Rainer König; Kathrin Schmidt; William-Edmund Hull; Stefan M Pfister; Manfred Jugold; Susan M Hutson; Christoph Plass; Jürgen G Okun; Guido Reifenberger; Peter Lichter; Bernhard Radlwimmer
Journal:  Nat Med       Date:  2013-06-23       Impact factor: 53.440

Review 3.  Medulloblastoma epigenetics and the path to clinical innovation.

Authors:  Amanda R Haltom; Stephanie A Toll; Donghang Cheng; Shinji Maegawa; Vidya Gopalakrishnan; Soumen Khatua
Journal:  J Neurooncol       Date:  2020-08-20       Impact factor: 4.130

4.  Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.

Authors:  Marc Remke; Esther Hering; Nicolas U Gerber; Marcel Kool; Dominik Sturm; Christian H Rickert; Joachim Gerß; Stefan Schulz; Thomas Hielscher; Martin Hasselblatt; Astrid Jeibmann; Volkmar Hans; Vijay Ramaswamy; Michael D Taylor; Torsten Pietsch; Stefan Rutkowski; Andrey Korshunov; Carmelia-Maria Monoranu; Michael C Frühwald
Journal:  Childs Nerv Syst       Date:  2013-05-16       Impact factor: 1.475

Review 5.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

6.  Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.

Authors:  Brian L Murphy; Susanna Obad; Laure Bihannic; Olivier Ayrault; Frederique Zindy; Sakari Kauppinen; Martine F Roussel
Journal:  Cancer Res       Date:  2013-10-21       Impact factor: 12.701

Review 7.  From small to big: microRNAs as new players in medulloblastomas.

Authors:  Feng Zhi; Suinuan Wang; Rong Wang; Xiwei Xia; Yilin Yang
Journal:  Tumour Biol       Date:  2012-11-25

Review 8.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

Review 9.  Role of MYC in Medulloblastoma.

Authors:  Martine F Roussel; Giles W Robinson
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

10.  Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis.

Authors:  Qingjuan Meng; Ningning Wang; Guanglan Duan
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.